Consensus Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq 04:00:00 2024-05-17 pm EDT 5-day change 1st Jan Change
26.43 USD +0.34% Intraday chart for Cartesian Therapeutics, Inc. +24.85% +27.79%

Evolution of the average Target Price on Cartesian Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

9c.oTWGihUOW0gAWAA4yW8AqhgyBN9IRWbIEjU-8MWNCyE.lk3hu2ZqFg42GXJumTg371JEXLYudTWje2R3hr_3OGXCd-3rXmwTGnZrNA~1ddb1407c94e36734cea4df637eb31c6

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
26.43 USD
Average target price
56.25 USD
Spread / Average Target
+112.83%
High Price Target
90 USD
Spread / Highest target
+240.52%
Low Price Target
39 USD
Spread / Lowest Target
+47.56%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cartesian Therapeutics, Inc.

Leerink Partners
Mizuho Securities
Needham & Co.
HC Wainwright
Canaccord Genuity
SVB Securities LLC
BTIG
William Blair & Co.
  1. Stock Market
  2. Equities
  3. RNAC Stock
  4. Consensus Cartesian Therapeutics, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW